Cambrooke Therapeutics

Get Full Access

Description

  • Cambrooke Therapeutics (expansion of Cambrooke Foods) was founded in 2000 by Lynn and David Paolella, the parents of two children diagnosed with a rare disease called phenylketonuria (PKU). PKU is one of the few genetic diseases, which is managed almost entirely with nutritional intervention. The Paolellas goal in forming Cambrooke was simple - to develop improved nutritional therapeutic options for those with serious medical disorders.Today, Cambrooke produces medical formulas and foods for the management of a variety of medical conditions and we are continually innovating new nutritional options targeted at a wide array of diseases.Cambrooke Therapeutics. Leaders in Medical Nutrition.Cambrooke was the first medical foods company to launch a natural intact protein for the dietary management of phenylketonuria called Glytactin (modified glycomacropeptide).Cambrooke collaborates with academia and industry partners to transform early phase development projects in therapeutic nutrition into viable commercial products.Cambrooke employs scientific experts in the development, manufacturing and commercialization of nutritional therapeutics for patients with rare diseases.Cambrookes products are supported by clinical evidence for the nutritional management of medical needs before they are selected for commercialization.Cambrooke believes that both large and small patient populations are important when it comes to complex nutritional requirements.
  • location

    Headquarters:4 Copeland Drive , Ayer, Massachusetts, United States

    More
  • Cambrooke Therapeutics phone

    Phone Number: +1 866-456-9776

  • Cambrooke Therapeutics website

    Website: https://www.cambrooke.com

  • Cambrooke Therapeutics employees

    Employees:49

  • Cambrooke Therapeutics revenue

    Revenue:$10 - 50M

  • Cambrooke Therapeutics legal name

    Legal Name:Cambrooke Therapeutics

  • Cambrooke Therapeutics's Social Media

    Cambrooke Therapeutics linkedin Cambrooke Therapeutics facebook Cambrooke Therapeutics twitter
  • done Is this data correct?
  • |  NAICS Code: 445110  |

    Show More
Person level website identification

Vice President International Operations for Cambrooke Therapeutics

Panayiotis Charalambous

Vice President International Operations

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Panayiotis Charalambous

Vice President International Operations

Steve Depew

Senior Vice President Of Operations

Don Patterson

Vice President Operations

Natasha Raimondo

North American Director Of Sales

Susan Gingrich

Director Medical Nutrition

Frequently Asked Questions regarding Cambrooke Therapeutics

  • Where are Cambrooke Therapeutics's Headquarters?

    Cambrooke Therapeutics's Headquarters are in 4 Copeland Drive ,Ayer,Massachusetts,United States

  • What is Cambrooke Therapeutics's phone number?

    Cambrooke Therapeutics's phone number is +1 866-456-9776

  • What is Cambrooke Therapeutics's official website?

    Cambrooke Therapeutics's official website is https://www.cambrooke.com

  • What is Cambrooke Therapeutics's Revenue?

    Cambrooke Therapeutics's revenue is $10 - 50M

  • What is Cambrooke Therapeutics's NAICS code?

    Cambrooke Therapeutics's NAICS code is 445110

  • How many employees are working in Cambrooke Therapeutics

    Cambrooke Therapeutics has 49 employees

  • What is Cambrooke Therapeutics's Industry?

    Cambrooke Therapeutics is in the industry of Pharmaceuticals

  • Who is Cambrooke Therapeutics's Vice President International Operations?

    Cambrooke Therapeutics's Vice President International Operations is Panayiotis Charalambous

Company Directory